Senzime Secures New TetraGraph Contract with State-Wide University Hospital System in Southern US

April 29, 2025 3:20 AM

Senzime (STO:SEZI)(OTCQX:SNZZF) - Uppsala, Sweden - Senzime AB today announced that it has secured another major US contract, this time with a top-ranked, state-wide university hospital system located in the southern US. The initial order includes 60 TetraGraph systems, with the potential to monitor more than 15,000 patients per year."This new hospital system contract was awarded without a clinical evaluation, showcasing the strength of our...

Read more

XVIVO Presents 12-Month Follow-Up Results from European Multicenter Heart Transplantation Trial at ISHLT in Boston

April 29, 2025 2:20 AM

XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV) - The 12-month follow-up results from XVIVO's European multicenter heart trial, NIHP2019, was presented at the 2025 International Society for Heart and Lung Transplantation (ISHLT) Annual Meeting in Boston, USA. The trial focused on heart transplantation outcomes using XVIVO Heart Assist Transport.The long-term analysis of the NIHP2019 trial evaluated patient outcomes 12 months...

Read more

Cantargia Announces Selection of Treatment Resistant Atopic Dermatitis as Second Target Indication for CAN10

April 29, 2025 1:50 AM

Cantargia (STO:CANTA)Atopic dermatitis (AD) is a very common, heterogeneous and debilitating disease with a need for new treatment optionsCAN10 targets several pathways relevant for AD but distinct from current treatments' mode of actionA pilot phase 2 study will test CAN10 in a subgroup of patients with moderate to severe AD not responding to current first line biologic treatmentClinical results expected within 12 months of study...

Read more

How to Choose the Right Compounding Pharmacy for Your Patients' Unique Needs: My Compounding Pharmacy Discusses How Their Tailored Services Can Benefit Australian Patients

April 28, 2025 6:00 PM

Providing optimal care for patients often means tailoring treatments to address their specific health challenges. For this reason, finding a reliable compounding pharmacy is vital for specialists like gastroenterologists, dermatologists, fertility experts, and other medical professionals looking to offer customized solutions that standard medications cannot provide.Compounding pharmacies, like My Compounding Pharmacy in Australia, play a key...

Read more

Former MetroHealth CEO, Dr. Airica Steed's Advocacy for Equity Amid CMS Funding Reductions

April 28, 2025 3:45 PM

Healthcare equity is a vision that requires relentless dedication, nuanced leadership, and a commitment to addressing the root causes of systemic disparities. Dr. Airica Steed exemplifies these qualities as she tackles the pressing challenge of reduced funding for social needs programs by the Centers for Medicare and Medicaid Services (CMS). With storied experience as a healthcare leader and a fierce advocate for marginalized communities, former...

Read more

Thoracic Myelopathy Uncovered: Dr. Hooman Melamed's Breakthrough Motion-Sparing Spine Surgery

April 28, 2025 1:20 PM

In the realm of spinal disorders, few conditions are as elusive - and misunderstood - as Thoracic Myelopathy. This severely underdiagnosed condition leaves countless patients navigating a maze of doctors, tests, and misdiagnoses, often being told that nothing is wrong despite persistent, unexplained symptoms. Dr. Hooman Melamed, an esteemed Orthopedic Spine Surgeon in Beverly Hills Los Angeles County, is redefining the approach to this complex...

Read more

Instant Transportation Featured in Online Spotlight for Its Reliable Local Service

April 28, 2025 12:30 PM

Instant Transportation, a trusted transportation service provider based in Worcester, Massachusetts, is the subject of a recent online spotlight feature highlighting the company's steady commitment to serving local individuals, patients, and businesses with care and consistency.The article, titled "The Quiet Fix: Instant Transportation's Simple Approach to Moving People in Worcester," offers a rare behind-the-scenes look at the small but...

Read more

The Assistance Fund Opens New Program for Eosinophilic Esophagitis

April 28, 2025 12:00 PM

The Assistance Fund, an independent charitable patient assistance organization that helps patients and families facing high medical out-of-pocket costs, today announced the launch of a new copay assistance program for people living with eosinophilic esophagitis. The program is designed to help eligible individuals pay for their out-of-pocket medical costs for treatment, such as copays, coinsurance, and deductibles.Eosinophilic esophagitis is a...

Read more

The Future of Spine Care: Dr. Hooman Melamed's Groundbreaking Motion - Sparing Technologies

April 28, 2025 11:55 AM

In the heart of Beverly Hills, Dr. Hooman Melamed is redefining spine surgery with cutting-edge motion-sparing technologies - offering renewed hope to patients once told spinal fusion was their only option. As a world-renowned Orthopedic Spine Surgeon, Dr. Melamed's pioneering techniques are reshaping outcomes for those suffering from debilitating spine conditions like Spinal Canal Stenosis, Scoliosis, Kyphosis, Sciatica, Radiculopathy, Back...

Read more

Champions Oncology Obtains Radioactive Materials License to Advance Comprehensive Radiotherapeutic Studies In-House

April 28, 2025 9:45 AM

Champions Oncology (NASDAQ:CSBR), a leader in translational oncology research, has been granted a license to use radioactive materials in preclinical studies. This approval allows in-house work utilizing a variety of clinically relevant radionuclides, significantly expanding the organization's capabilities in the development and assessment of targeted radiotherapeutics.Through this license, Champions Oncology is now uniquely positioned to...

Read more

MentalHealth.com Acquires Provider of Mental Health Resources and Clinical Guidelines

April 28, 2025 9:15 AM

Leading health technology company MentalHealth.com is pleased to announce its acquisition of online mental health resource and clinical guidelines provider, PsychGuides.com.Founded in 1996, PsychGuides.com has been a longstanding provider of research-based mental health information, serving clinicians, policymakers, and patient advocates. Committed to advancing evidence-based care, it has collaborated with leading organizations, including Abbott...

Read more

Healthcare Leaders Sound Alarm: 93% Concerned About ACA Rollbacks, Rising Costs, Workforce Instability, and Regulatory Shifts Under Trump Administration’s Policy Changes, Black Book Reports

April 28, 2025 8:30 AM

Black Book Research today released findings from six exclusive surveys conducted between January 22 and April 27. 2025, capturing the concerns of 1,664 healthcare leaders across hospitals, health systems, payers, and more.These leaders provide a clear view of the far-reaching effects of early policy decisions in President Trump's second term, revealing rising costs, workforce instability, and access to care disruptions.The findings highlight how...

Read more

Jaguar Health to Present Initial Results from the Proof-of-Concept Study of Crofelemer for the Rare Diseases Microvillus Inclusion Disease (MVID) and Short Bowel Syndrome with Intestinal Failure (SBS-IF) During an April 30 Investor Webcast

April 28, 2025 8:15 AM

Jaguar Health, Inc. (NASDAQ:JAGX) (Jaguar) family companies Napo Pharmaceuticals (Napo) and Napo Therapeutics today announced that Jaguar is hosting an investor webcast on Wednesday, April 30, 2025 at 8:30 AM Eastern to review the initial results of the proof-of-concept (POC) investigator-initiated trial (IIT) of a novel liquid formulation of crofelemer, Jaguar's plant-based anti-secretory prescription drug, in patients with the rare diseases...

Read more

Ambience Healthcare Collaborates with Houston Methodist to Revolutionize Emergency and Inpatient Care

April 28, 2025 8:05 AM

Ambience Healthcare, a leader in ambient AI technology, today announced that it is expanding its testing of ambient AI in two high-acuity care settings: emergency (ED) and inpatient care. This new engagement marks the release of Ambience's new care setting solutions to support ED and inpatient clinicians, building upon Ambience's 100+ specialty-tuned offerings.Houston Methodist ED and inpatient clinicians leverage Ambience's new solutions in...

Read more

Progressive Supranuclear Palsy Phase 2 Platform Clinical Trial Announces the Selection of AADvac1 and AZP2006 for its First Two Regimens

April 28, 2025 8:00 AM

The Progressive Supranuclear Palsy (PSP) Trial Platform (PTP), led by Drs. Adam Boxer (University of California, San Francisco [UCSF]), Irene Litvan (University of California, San Diego), Julio Rojas (UCSF) and Anne-Marie Wills (Massachusetts General Hospital), has selected two promising drug candidates-Axon Neuroscience's AADvac1 and Alzprotect's AZP2006-for inclusion in the platform trial as the first two compounds to be evaluated. The trial...

Read more

Hemogenyx Pharmaceuticals PLC Announces Final Results

April 28, 2025 2:00 AM

Hemogenyx Pharmaceuticals plc (LSE: HEMO), the biopharmaceutical group developing new therapies and treatments for blood diseases, announces its final audited results for the year ended 31 December 2024. The Annual Report is available to view on the Company's website at https://hemogenyx.com/.Key HighlightsThe Company commenced Phase I clinical trials of its HG-CT-1 product candidate.Continuing development of Chimeric Bait Receptor...

Read more

Cantargia Announces the Publication of Preclinical Data Highlighting Nadunolimab's Potential to Counteract Tumor-Driven Systemic Immunosuppression

April 28, 2025 1:20 AM

Cantargia (STO:CANTA)Preclinical data shows IL1 family signals mediate systemic immune suppression.Blocking IL1RAP can overcome resistance to immune therapy in a cervical cancer model.Clinical findings from nadunolimab studies reflect these preclinical effects of IL1RAP blockade and suggest translatability to clinical benefit.Cantargia (Cantargia AB (publ); Nasdaq Stockholm: CANTA) today reported the publication of preclinical results in the...

Read more

ACA Enrollees Face Growing Coverage Crisis: Black Book Survey Signals Rising Fears Amid Economic Instability and Proposed Healthcare Rollbacks

April 26, 2025 2:45 PM

A national survey by Black Book Research indicates significant concerns and widespread opposition among Affordable Care Act (ACA) enrollees toward proposed healthcare policy changes under the current administration. Conducted between March 5 and April 20, 2025, the survey gathered insights from 1,000 ACA participants across 28 states (as of the 2025 plan year, these states utilize the Federally Facilitated Marketplace, accessing health insurance...

Read more

Medicure Reports Financial Results for Quarter and Year Ended December 31, 2024

April 25, 2025 5:01 PM

Medicure Inc. (" Medicure " or the " Company ") (TSXV:MPH)(OTC PINK:MCUJF), a company focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market, today reported its results from operations for the quarter and year ended December 31, 2024.Quarter and Year Ended December 31, 2024 Highlights:Recorded total net revenue of $21.9 million during the year ended...

Read more

IRLAB publishes the Annual Report for 2024

April 25, 2025 4:00 PM

IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) - Gothenburg, Sweden, April 25, 2025 - IRLAB Therapeutics AB (Nasdaq Stockholm:IRLAB A), a company discovering and developing novel treatments for Parkinson's disease, announced today that the Annual Report for 2024 is published on the company's website, www.irlab.se.IRLAB has published the Annual Report 2024 for the financial year, which covers January 1 to December 31, 2024. The Annual Report is...

Read more